TrialClinical and experimental hypertension (New York, N.Y. : 1993)2016

Safety and tolerability of azilsartan medoxomil in subjects with essential hypertension: a one-year, phase 3, open-label study.

Alison Handley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.